Investing In Africa: The Abraaj Story

Abraaj has done well in North Africa despite the regional turmoil. It has invested $1.7 billion here since 2006. Last year the group exited from a 2009 investment in the Tunisian Opalia Pharma SA by selling a 90-percent stake to the Italian pharmaceutical maker, Recordati. Opalia recorded a 250-percent increase in sales over the course of Abraaj’s ownership. “The sectors that we’ve invested in North Africa range from financial services, basic materials, FMCG [Fast Moving Consumer Goods], healthcare – including on the service side and on the manufacturing side in pharmaceuticals. We’ve also invested in education. We’ve invested in utility services, business services and IT [Information Technology] outsourcing,” said Badreldin.
http://www.ventures-africa.com/2014/05/investing-in-africa-the-abraaj-story/